How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Blood Flow Measurement Devices (Ultrasonic Doppler, Laser Doppler and Electromagnetic Blood Flowmeters) Market
- By Technology: Ultrasonic Doppler Flowmeters, Laser Doppler Flowmeters, Electromagnetic Flowmeters, Thermal Dilution Flowmeters, Transit-Time Ultrasonic Flowmeters
- By Application: Cardiology, Vascular Surgery, Neurosurgery, Peripheral Artery Disease Diagnosis, Research and Development
- By End User: Hospitals and Clinics, Diagnostic Laboratories, Research Institutes, Ambulatory Surgical Centers, Cardiology Centers
- By Product Type: Handheld Blood Flow Meters, Intravascular Flow Probes, Implantable Flow Sensors, Desktop Blood Flow Analyzers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Ultrasonic Doppler Flowmeters leads By Technology at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 279 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.168 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.176 →
Full report · locked preview
Everything inside the Blood Flow Measurement Devices (Ultrasonic Doppler, Laser Doppler and Electromagnetic Blood Flowmeters) Market report
A complete, evidence-based study - 11 chapters and 117 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Technology 5
Application 5
End User 5
Product Type 4
Companies profiled
Medtronic plc
GE Healthcare
Philips Healthcare
Siemens Healthineers
Edwards Lifesciences Corporation
Nihon Kohden Corporation
Transonic Systems Inc.
Imagent LLC
MediLumine Inc.
Moor Instruments Ltd.
Vista Medical Ltd.
Triton Technology Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →GE Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Edwards Lifesciences Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Nihon Kohden Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Transonic Systems Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Imagent LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →MediLumine Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Moor Instruments Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Vista Medical Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Triton Technology Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →BioMed Innovations Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Fukuda Denshi Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →
Global · 2025–2033
$2,632M by 2033 · 11.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Ultrasonic Doppler Flowmeters50.1
- Laser Doppler Flowmeters11.8
- Electromagnetic Flowmeters15.2
- Thermal Dilution Flowmeters12.3
- Transit-Time Ultrasonic Flowmeters10.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$362.5M → $896.7M · 12.0%
Europe$252.6M → $622.0M · 11.9%
Asia Pacific$230.7M → $548.4M · 11.4%
Latin America$142.8M → $374.9M · 12.8%
Middle East and Africa$109.8M → $282.6M · 12.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.492026
11.512027
11.512028
11.532029
11.542030
11.552031
11.572032
11.572033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medtronic plc25.4
- GE Healthcare9.5
- Philips Healthcare11.9
- Siemens Healthineers10.6
- Edwards Lifesciences Corporation10.4
- Nihon Kohden Corporation4.2
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Technology29.4%
Application26.0%
End User15.7%
Product Type28.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.9
- Europe22.8
- Asia Pacific20.1
- Latin America13.8
- Middle East and Africa10.4
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medtronic plc | 83 | 96 | 89 | 92 | 99 | 86 | 91 |
| GE Healthcare | 84 | 75 | 71 | 72 | 91 | 92 | 81 |
| Philips Healthcare | 82 | 80 | 67 | 65 | 65 | 86 | 74 |
| Siemens Healthineers | 57 | 63 | 72 | 64 | 57 | 79 | 65 |
| Edwards Lifesciences Corporation | 68 | 76 | 72 | 66 | 56 | 62 | 67 |
| Nihon Kohden Corporation | 70 | 64 | 67 | 65 | 57 | 71 | 66 |
| Transonic Systems Inc. | 42 | 64 | 51 | 57 | 46 | 50 | 52 |
| Imagent LLC | 40 | 42 | 56 | 36 | 35 | 59 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medtronic plc
- GE Healthcare
- Philips Healthcare
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medtronic plc | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| GE Healthcare | ◐ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Philips Healthcare | ◐ | ✓ | ◐ | ◐ | − | ✓ |
| Siemens Healthineers | ◐ | ◐ | ◐ | ✓ | ◐ | ✓ |
| Edwards Lifesciences Corporation | ✓ | ✓ | ◐ | ✓ | − | − |
| Nihon Kohden Corporation | ◐ | − | ◐ | ✓ | ◐ | ✓ |
| Transonic Systems Inc. | − | ◐ | ◐ | − | − | − |
| Imagent LLC | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Medtronic plc91
2GE Healthcare81
3Philips Healthcare74
4Edwards Lifesciences Corporation67
5Nihon Kohden Corporation66
6Siemens Healthineers65
7Transonic Systems Inc.52
8Imagent LLC45
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Medtronic plcGE Healthcare
Challenger2
Strong scale, closing on the leaders.
Philips HealthcareEdwards Lifesciences Corporation
Contender2
Focused players with pockets of strength.
Siemens HealthineersNihon Kohden Corporation
Niche2
Specialists in a single segment or region.
Transonic Systems Inc.Imagent LLC
Go-to-market strategy
Land Technology in North America, then scale across Blood Flow Measurement Devices (Ultrasonic Doppler, Laser Doppler and Electromagnetic Blood Flowmeters) Market — a $282M beachhead inside a $4.66B market.
Beachhead (SOM)$282Mobtainable near-term
Serviceable (SAM)$1.87Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Ultrasonic Doppler Flowmeters
Best fit — highest urgency & budget in Technology.
Economic buyer78 fit
Laser Doppler Flowmeters
Strong fit — clear ROI and a fast path to value.
End user67 fit
Electromagnetic Flowmeters
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Technology in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel26%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Technology leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Blood Flow Measurement Devices (Ultrasonic Doppler, Laser Doppler and Electromagnetic Blood Flowmeters) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified25%
Evaluation12%
Closed-won6%
$16.1KCAC
$84KLTV
5.2:1LTV : CAC
< 3 moCAC payback
Investment thesis
Blood Flow Measurement Devices (Ultrasonic Doppler, Laser Doppler and Electromagnetic Blood Flowmeters) Market is a durable-growth opportunity — $1.86B by 2033, compounding at 8.1%.
TAM · 2025$995Mtoday
TAM · 2033$1.86Bforecast
CAGR8.1%2027–2033
Cumulative$12.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.86BTotal addressable market
SAM$713MServiceable available market
SOM$117MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.1% CAGR
Demand compounds through 2033, outpacing GDP across Technology.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Technology moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.86BLarge & growingTAM by 2033 at 8.1% CAGR
$713MServiceable nowreachable with today’s model
$117MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.45BBear5.3% CAGR
$1.86BBase8.1% CAGR
$2.38BBull10.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Blood Flow Measurement Devices (Ultrasonic Doppler, Laser Doppler and Electromagnetic Blood Flowmeters) Market — a $8.27B market by 2033. Plan: grow share from 8.0% to 15.6%.
Market size · 2033$8.27Btotal addressable
Market CAGR7.7%2027–2033
Target share15.6%from 8.0% today
Revenue ambition$1.29Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.0% | 15.6% | Behind |
| Revenue | $727M | $1.29B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 37.9% | 41.1% | On track |
| Customer retention | 86.6% | 96.6% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Technology
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Technology share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $157M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Technology leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentAhead
Sales deck · value proposition
Win the Blood Flow Measurement Devices (Ultrasonic Doppler, Laser Doppler and Electromagnetic Blood Flowmeters) Market conversation — a $10.4B market you can size, segment and defend in minutes.
Market size · 2033$10.4Btotal opportunity
Growth10.9%CAGR to 2033
Addressable buyers1,425+accounts in scope
Typical ROI6.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Technology
Goal Grow share in Technology
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.3×return on cost, year one
< 3 mopayback period
$84K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Medtronic plcGE HealthcarePhilips HealthcareSiemens HealthineersEdwards Lifesciences CorporationNihon Kohden CorporationTransonic Systems Inc.Imagent LLC+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Blood Flow Measurement Devices (Ultrasonic Doppler, Laser Doppler and Electromagnetic Blood Flowmeters) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Blood Flow Measurement Devices (Ultrasonic Doppler, Laser Doppler and Electromagnetic Blood Flowmeters) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Blood Flow Restriction Bands Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportBlood Gas Analyzer with Touchscreen Market
Market size, share, segmentation and regional forecast.
$698M market · 2025 base year
View reportBlood Gas Analyzer/Blood Gas and Electrolyte Analyzer Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportBlood Gas Electrolyte Analyzer Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportBlood Glucometer Market
Market size, share, segmentation and regional forecast.
$967M market · 2025 base year
View reportBlood Glucose (SMBG) (Test Strips, Lancet, Meter) Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportBlood Glucose Devices Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportBlood Glucose Meter Accessorie Market
Market size, share, segmentation and regional forecast.
$842M market · 2025 base year
View reportBlood Glucose Meter, Blood Glucose Detection Test Disc (Glucose Oxidase) Market
Market size, share, segmentation and regional forecast.
$788M market · 2025 base year
View reportBlood Glucose Meters - Pipeline Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportBlood Glucose Monitor Market
Blood Glucose Monitor Market is valued at USD 7.2 Billion in 2025 and is expected to reach USD …
$7.2B market · 2025 base year
View reportBlood Glucose Monitoring Consumables Market
Market size, share, segmentation and regional forecast.
$965M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.